Picture of Biomerica logo

BMRA Biomerica Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Annual cashflow statement for Biomerica, fiscal year end - May 31st, USD millions except per share, conversion factor applied.

2017
May 31st
2018
May 31st
2019
May 31st
2020
May 31st
2021
May 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-0.909-1.47-2.39-2.34-6.47
Depreciation
Deferred Taxes
Non-Cash Items0.0470.0340.1730.4862.93
Unusual Items
Other Non-Cash Items
Changes in Working Capital-0.080.04-0.197-2.57-1.85
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-0.723-1.17-2.24-4.3-5.25
Capital Expenditures-0.096-0.13-0.171-0.119-0.296
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Cash from Investing Activities-0.096-0.13-0.171-0.119-0.296
Financing Cash Flow Items0.009
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Cash from Financing Activities0.1581.291.9112.41.11
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-0.663-0.021-0.5187.95-4.44

Or unlock with your email

Or unlock with your email